Posts Tagged ‘medical’



January 25th, 2017

Public Sector Risk Financing Perspectives – Pandemic Risk

Posted at 1:00 AM ET

cory-anger-small-sqCory Anger, Global Head of ILS Structuring, GC Securities*

Contact

Public entities’ use of capital markets-based risk transfer capacity for the assumption of natural disaster losses, such as the cost of emergency relief and infrastructure and property damage has demonstrated success in de-risking public sector balance sheets. Capital markets innovators are beginning to leverage the outcomes achieved in the natural disaster sphere to other types of public sector severity losses, notably pandemic diseases. The capital markets may help fund resources to rapidly contain the spread of a pandemic, share the burden of associated medical expenses and/or manage the financial impact of the higher mortality rates.

Continue reading…

September 27th, 2016

Longevity Risk

Posted at 1:00 AM ET

The impacts to society from changes in longevity and life expectancy will be wide-ranging and incredibly difficult issues to grapple with. A 2012 International Monetary Fund (IMF) study revealed that if individuals lived three years longer than expected the cost of aging could increase by 50 percent. This translates to 50 percent of 2010 gross domestic product (GDP) in advanced economies and 25 percent of 2010 GDP in emerging economies. Globally that amounts to tens of trillions of US dollars. The United Nations expects the aggregate expenses of the elderly will double over the period between 2010 and 2050. The figure below shows the projected trend of rising life expectancy to continue in all regions of the globe regardless of economic advancement.

Continue reading…

August 16th, 2016

Advancing Technologies Raise Issues for (Re)insurers

Posted at 1:00 AM ET

Here we review GC Capital Ideas posts on advancing technologies that are creating new opportunities and new risks for (re)insurers.

Continue reading…

August 1st, 2016

New Economics Are Creating New Medicine, Part II

Posted at 1:00 AM ET

Predictive analytics or predictive medicine uses patient-specific data and enables a more customized, precise approach for patient-specific treatment. With the insight this provides, biotechnology, pharmaceutical and medical device companies can partner to provide better care, improve compliance, lower readmission rates and drive improved outcomes. This can lower unnecessary and ineffective treatments and decrease the overall cost of care. However, taken to an extreme scenario, life science companies could invest in developing much more specific treatments for very small cohorts of affected patients. These focused therapies could be extremely expensive and would be wildly impractical without the intersection of new technology and new economics.

Continue reading…

July 28th, 2016

New Economics Are Creating New Medicine, Part I

Posted at 1:00 AM ET

Through the Affordable Care Act, many measures are being implemented that are expected to have a positive impact on bending the healthcare cost curve downward in the long term. However, the same act removed annual and lifetime limits for medical insurance claims. As a result, the maximum potential loss from a single individual is a new frontier of risk, with new heights being reached each year. This is both a frequency and severity issue.

Continue reading…

April 20th, 2016

Emerging Risks for Life, Health and Longevity

Posted at 1:00 AM ET

Here we review recent GC Capital Ideas posts on the emerging risks affecting life, health and longevity. 

Continue reading…

November 16th, 2015

New Economics Are Creating New Medicine

Posted at 1:00 AM ET

Through the Affordable Care Act, many measures are being implemented that are expected to have a positive impact on bending the healthcare cost curve downward in the long term. However, the same act removed annual and lifetime limits for medical insurance claims. As a result, the maximum potential loss from a single individual is a new frontier of risk, with new heights being reached each year. This is both a frequency and severity issue.

Continue reading…

November 12th, 2015

Escalating Medical Costs

Posted at 1:00 AM ET

The impact of rising healthcare expenses has been and will continue to be felt around the world, in developed and undeveloped nations alike. Rising healthcare costs are putting a strain on governments worldwide. Nowhere in the world, however, are expenses as high as they are in the United States, where the impact extends into the medical component of workers compensation costs. Although the rate of growth has seen some stability, it still outpaces the US growth rate of inflation. The figure below illustrates that per capita spending in the United States in 2010 was over USD 8,000. A key driver for higher US costs is that it spends more on hospital care and medical specialists. Hospital costs are 60 percent higher in the United States than in other Organization of Economic Cooperation and Development countries. Spending on the use of specialists is more than two times higher. Forecasters believe this trend will increase. 

Continue reading…

November 11th, 2015

Longevity Risk

Posted at 1:00 AM ET

The impacts to society from changes in longevity and life expectancy will be wide-ranging and incredibly difficult issues to grapple with. A 2012 International Monetary Fund (IMF) study revealed that if individuals lived three years longer than expected the cost of aging could increase by 50 percent. This translates to 50 percent of 2010 gross domestic product (GDP) in advanced economies and 25 percent of 2010 GDP in emerging economies. Globally that amounts to tens of trillions of US dollars. The United Nations expects the aggregate expenses of the elderly will double over the period between 2010 and 2050. The figure below shows the projected trend of rising life expectancy to continue in all regions of the globe regardless of economic advancement.

Continue reading…

November 10th, 2015

Life, Health and Longevity Emerging Risks

Posted at 1:00 AM ET

In the last 150 years, dramatic improvements have been made in life expectancy. Some developments such as immunizations for smallpox, polio and measles created quantum improvements, while the proliferation of better lifestyles, clean water and more nutritious diets provided gradual and continuing change. While most historical life expectancy developments resulted from improvement in children’s mortality, in the 20th century, mortality rates declined significantly for older ages.

Continue reading…